EASEE® System Pivotal Study for the United States of America

Clinical trial NCT07301346 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07301346
Sponsor: Precisis US, Inc.
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Drug-Resistant Focal Epilepsy

Start date: 2026-07-01
Primary completion: 2029-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.